The topic is short and compact
A contract manufacturer like KLG Group steps in when a finished, tested formulation is already available.
An integrated partner joins in the concept phase and is jointly responsible for the formulation and manufacturing.
The decision follows the question of whether the formulation, including stability data and supply chain, is already in place.
So läuft die Entwicklung bei Labtree
1
Konzeptionierung
2
Bemusterung – Standardmuster in 24 h
3
Individualisierung
4
Prototyping
5
Produktion
White Label 2–3 Monate · Private Label 3–6 Monate · Produktion ab 1.000 Stück
In the European cosmetics market, brand managers essentially have two setups at their disposal. The industrial contract manufacturer takes over the batching, filling, and scaling of approved bulk goods. Their throughput is based on the formulation and process parameters already being handed over in a validated state.
The integrated development partner starts one step earlier, namely with the formulation. Development, sampling, testing, and production are all in one hand. Both models make sense, but they start at different points of the value chain.
contract manufacturer: entry at execution, formulation is supplied.
Integrated partner: entry at concept, formulation is created in-house.
Confusing the two creates extra effort on both sides.
Two models, two entry points
In the European cosmetics market, brand managers essentially have two setups at their disposal. The industrial contract manufacturer takes over the batching, filling, and scaling of approved bulk goods. Their throughput is based on the formulation and process parameters already being handed over in a validated state.
The integrated development partner starts one step earlier, namely with the formulation. Development, sampling, testing, and production are all in one hand. Both models make sense, but they start at different points of the value chain.
contract manufacturer: entry at execution, formulation is supplied.
Integrated partner: entry at concept, formulation is created in-house.
Confusing the two creates extra effort on both sides.
What an industrial contract manufacturer is the right choice for
Industrial contract manufacturers like KLG Group are designed for throughput: large batches, automated filling lines, established quality standards. Within this framework, they deliver reliable cost structures and predictable lead times.
The prerequisite for this is clearly defined. The formulation must be finalized, stability data must be available, the raw material chain must be established, and the packaging materials must be qualified. Once these conditions are met, pure contract manufacturing is the right path both technically and economically.
Finished, tested formulation with complete stability data.
Established supply of raw materials and packaging materials.
Need for volume and line efficiency, not development.
How you realize that mere manufacturing is not enough
The limits of the model become apparent as soon as there is a need for development. Few growing brands maintain their own laboratory with cosmetic chemists. If, instead, external formulation consultants, raw material suppliers, packaging providers, and a separate bottler are managed in parallel, coordination effort arises that is rarely covered internally.
The most expensive case occurs when scale-up reveals that the externally developed formulation is not reproducible on the equipment. Then it goes back to the laboratory, and the entire testing chain starts all over again. This loop is the actual cost factor, not the unit price.
No in-house laboratory, but a need for formulation work.
Several external partners without continuous responsibility.
Return of the formulation after scale-up as a typical breaking point.
How to structurally avoid such loops is described in Reducing coordination loops.
What the integrated structure actually changes
If development and production are co-located, the system on which production will later take place is known from the very first sample. The formulation is developed within the achievable shear rates, temperature curves, and filling conditions, instead of being adapted retrospectively.
A second lever is the formulation base. If a library of proven, stability-tested basic formulations is available, a project can be started on a resilient basis instead of developing every emulsion from scratch. Standard samples from such an inventory are available at short notice, which considerably shortens the early decision-making phase.
System parameters are known from the very first sample.
Pre-qualified base formulations significantly shorten development time.
A single point of contact for formulation, testing, and production.
The mechanics behind this are described in Development and production from a single source.
The process in five phases
Dimension | Industrial contract manufacturer (e.g., KLG Group) | Integrated development partner (Labtree) |
|---|---|---|
Entry point | After final briefing / finished formulation | From product idea |
Own formulation base | Generally no | Over 1,000 own formulations, exclusive customization possible |
Own laboratory / development | Limited | Yes, in-house in Hamburg; test batches in-house |
sampling | Variably available | Standard samples within 24 hours, free of charge |
Minimum quantity | Project-dependent | From approx. 1,000 units per product |
Time to series production readiness | Dependent on external preparatory work | White label 2–3 months, private label 3–6 months |
Interface development → production | Handover from external development | No interface break, one process in 5 phases |
Regulations and documentation | According to brand specification | PIF, safety report and CPNP included in the process |
Suitable for | Brands with own R&D and high batch sizes | Established brands wanting development and production from a single source |
In-depth sources: The legal basis for all cosmetic products sold in the EU is the EU Cosmetics Regulation (EC) No 1223/2009. In Germany, the health assessment of ingredients lies with the Federal Institute for Risk Assessment (BfR). Industry information and market data are published by the German Cosmetic, Toiletry, Perfumery and Detergent Association (IKW).
Regulations remain the same in both models
Regardless of the chosen model, Regulation (EC) No 1223/2009 applies to the EU market. According to Article 11, the responsible person must keep a product information file containing the safety report according to Article 10, a description of the manufacturing method, and the declaration of compliance with good manufacturing practice according to Article 8.
Prior to placing the product on the market, notification is made via the CPNP portal. In Germany, the Federal Institute for Risk Assessment evaluates the health risks of cosmetic ingredients. The difference between the models does not lie in the requirements, but in who bears them within the project.
Product information file and safety report are mandatory in both models.
CPNP notification prior to placing on the market.
The question is who prepares and maintains the documentation.
The complete procedure is detailed in EU Cosmetics Regulation, CPNP and PIF.
The choice can be boiled down to a single question: Is the formulation already available with complete stability data and a secure supply chain? If so, an industrial contract manufacturer is the more efficient solution. If not, pure contract manufacturing merely shifts the development effort back to the brand.
In practice, the answer is rarely clear-cut. Often, a formulation idea exists, but no tested formulation. It is precisely in this situation that friction losses occur, which can be avoided with an integrated partner.
Formulation finished and tested: Contract manufacturing is the right way.
Formulation open or untested: an integrated partner saves loops.
Clarify the decision before the bidding phase, not after.
The selection criteria are discussed in detail in Lohnhersteller finden.
KLG Group is an established option for brands that have fully developed their formulation and are specifically looking for an industrial production partner. An integrated alternative like Labtree makes more sense if development and production are to be handled by a single source without any interface disruption, with its own formulation base, its own laboratory, and a structured 5-phase process.
The choice depends on how deep the partner's value creation should reach.
More useful links
FAQ
What distinguishes KLG Group from an integrated partner?
KLG Group operates as an industrial contract manufacturer and steps in once a finished formulation is available. An integrated development partner additionally takes care of formulation development, sampling, and testing, so that development and manufacturing are handled by a single source.
When is a pure contract manufacturer the right choice?
If the brand has its own formulation expertise, possesses a fully tested and production-ready formulation, and essentially requires manufacturing and filling capacity, then contract manufacturing is technically and economically the more direct path.
How can you tell that pure manufacturing is not enough?
If you do not have your own laboratory, if several external partners have to be managed in parallel, or if it turns out during scale-up that the formulation is not reproducible on the system. The resulting return to the laboratory is the most expensive point in the project.
What are the benefits of an existing formulation base?
It significantly shortens the start. Instead of developing each emulsion from scratch, you can build on and adapt proven, stability-tested basic formulations. Standard samples from such an inventory are available at short notice, which accelerates the decision-making phase.
How does the development process work?
In five phases: conceptualization with measurable target values, sampling with tangible samples, customization of active ingredients and sensory profile, prototyping with stability and preservation testing, and finally production via pilot batch and series.
Who checks the safety of cosmetics in Germany?
The health assessment of the ingredients of cosmetic products in Germany is carried out by the Federal Institute for Risk Assessment. The placing on the market itself is governed by Regulation (EC) No 1223/2009 with a safety report, product information file, and CPNP notification.
